• Eicosapentaenoic Acid: Applied Research Workflows

  2026-09-03

  Eicosapentaenoic Acid (EPA) supports distinct cardiovascular research workflows spanning membrane remodeling, endothelial cell migration inhibition, and lipoprotein oxidation assays. This practical guide shows how to use a characterized EPA omega-3 fatty acid preparation while avoiding oxidation, vehicle, and cross-domain interpretation errors.

• BAPTA for Calcium Signaling and Apoptosis

  2026-09-02

  BAPTA provides a practical way to test whether free Ca2+ is a causal driver of toxicant-induced cell death rather than a bystander signal. This workflow translates IP3R/Ca2+/STAT3 findings into controlled apoptosis research, calcium signaling modulation, and cell-based assay optimization.

• Scalable EPSC-Derived MSC EVs: Study Insights

  2026-09-02

  Gong and colleagues developed a bioreactor-based platform that converts extended pluripotent stem cells into induced mesenchymal stromal cells and scalable extracellular vesicle production. The study links standardized cell sourcing with continuous processing and demonstrates therapeutic activity in a bleomycin-induced pulmonary fibrosis model, while also identifying important translational gaps before clinical manufacturing.

• Dlin-MC3-DMA: From Delivery to Design

  2026-09-02

  Dlin-MC3-DMA is more than a benchmark ionizable lipid: it is a translational starting point for connecting endosomal escape, cargo-specific potency, cellular state, and machine-learning-guided formulation design. This article examines its mechanistic rationale, preclinical evidence, strategic positioning, and practical use in siRNA and mRNA programs.

• Imipenem: Mechanism and Research Applications

  2026-09-01

  Imipenem is a semisynthetic thienamycin antibiotic used in antibacterial research because it targets penicillin-binding proteins and inhibits bacterial cell-wall synthesis. Product data support broad activity, defined physicochemical handling parameters, and exploratory immune response modulation in cell and sepsis animal model studies.

• Probenecid Beyond MDR: A Translational Strategy

  2026-08-31

  Probenecid is more than an MRP inhibitor: it is a mechanistically broad research tool for separating transporter-mediated drug resistance, pannexin-1 activity, and injury-associated inflammatory responses. This article outlines how to use Probenecid in leukemia, cerebral ischemia/reperfusion, and exploratory immunometabolism studies without overstating cross-domain evidence.

• Spatial Control of Nuclear mTORC1 Signaling

  2026-08-31

  The reference study introduces TerminaTOR, a genetically encodable inhibitor that can selectively suppress mTORC1 at defined subcellular locations. Its results show that lysosomal and nuclear mTORC1 support distinct biological outputs, including autophagy control and transcription of CCAAT motif-containing genes.

• Tacrolimus (FK506): Reading Calcineurin Assays

  2026-08-30

  Tacrolimus and FK506 are often treated as simple calcineurin inhibitors, but their experimental meaning depends on immunophilin context, assay readouts, and exposure design. This guide connects molecular mechanism with genetically informed controls and reproducible model selection.

• Physiological and Pathological Aβ in Human Synapses

  2026-08-29

  McGeachan and colleagues use live human brain slice cultures to distinguish how physiological Aβ fluctuations differ from Alzheimer’s disease-associated Aβ in their effects on synapses. The study links donor characteristics and regional biomarker release to divergent structural, uptake, and transcriptional responses, providing a human-tissue framework for studying early synaptic pathology.

• Pazopanib Hydrochloride Cancer Assay Workflows

  2026-08-28

  Build more informative angiogenesis and tumor-response assays with Pazopanib Hydrochloride (GW786034), a multi-target kinase inhibitor suited to both signaling and phenotype studies. This workflow separates growth inhibition from cell killing so apparent potency is not mistaken for cytotoxicity.

• Y-27632: Reading Force, Shape, and Cell Fate

  2026-08-28

  Y-27632 is a selective ROCK inhibitor for dissecting how actomyosin tension, focal adhesions, and cell geometry influence experimental outcomes. This article translates MSC mechanobiology findings into a force-aware assay strategy that separates cytoskeletal dynamics modulation from downstream cell-fate interpretation.

• GSK2606414: A Causal PERK Probe for NAFLD

  2026-08-28

  GSK2606414 is a selective PERK inhibitor for testing whether ER-stress signaling drives metabolic liver injury. This article develops a causal assay framework around TMAO-induced NAFLD, connecting pathway engagement, phenotype rescue, selectivity, and experimental controls.

• Z-VDVAD-FMK: Reliable Caspase-2 Assays

  2026-08-27

  Learn how Z-VDVAD-FMK, SKU A1922, can improve interpretation of apoptosis, viability, and caspase activity experiments through pathway-focused inhibition and disciplined controls. This scenario-based guide covers assay design, DMSO preparation, storage, data interpretation, cross-domain limitations, and practical vendor selection.

• GOB-38 in Elizabethkingia anophelis: Biochemical Insights

  2026-08-26

  The reference study characterizes GOB-38, a B3-Q metallo-β-lactamase from a clinical Elizabethkingia anophelis isolate, using recombinant expression, purified-enzyme analysis, genomic investigation, and bacterial co-culture. Its broad hydrolytic profile and distinctive active-site residues help explain resistance to multiple β-lactam classes, while the co-isolation data raise important questions about resistance dissemination during polymicrobial infection.

• Imipenem as a Translational Resistance Lens

  2026-08-26

  Imipenem is more than a broad-spectrum antibacterial benchmark. Its PBP-directed mechanism, immune-response observations, and performance in resistance-focused workflows create a practical framework for linking bacterial phenotype, carbapenemase genetics, and sepsis biology. This thought-leadership guide shows translational researchers how to use Imipenem strategically while avoiding overinterpretation of in vitro, genomic, and animal-model findings.

8677 records 1/579 page Next 12345 下5页 Last page